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Tumor cells represent a single clone of cells that have 
undergone a series of mutations in genOl11ic DNA. 
This process, known as clonal evolution, is a distin-
guishing feature of cancer. The hUl11an androgen 
receptor gene (HUMARA; GenBank) contains a 
highly polymorphic cytosine-adenine-guanine trinu-
cleotide repeat that can be used to deterI11ine clonal-
ity by depicting X chromosome inactivation patterns. 
Random X chromosome inactivation is consistent 
w ith polyclonality; nonrandom. X chrom.osome inac-
tivation indicates a clonal population of cells. Basal 
cell carcinolua (Bee) demonstrates an atypical 
growth pattern in that it grows slowly, rarely metas-
tasizes, and is rarely lethal. Whether this tUluor 
results fron1 the acculllulation of mutations in a 
single cell with subsequent clonal expansion or re-
M o lecul ar studies of DNA fro l11 aggressive viscera l tumors ha ve show n that tumors result fro m a single clon e of ce ll s that has undergone a series o f mutatio ns in genomi c DNA (Cavan ee and White, 1995 ; Bishop , 199 1; Hunter. 1991). T his 
process, kn own as clonal evolu tion, is an important distin guishing 
fea ture of ca ncer (Cavanee and White, 1995) . In som e tumo rs, such 
as n eurofibroma, clo nal evolution character izes the transition fr0111 
a b enign to a malignant. state (Friedman eI ai , '1982). Previous 
srudies have sho wn the importan ce of c lo llali ty in understanding 
the disordered g rowth chara cteristi cs of cutaneous can cers such as 
histi ocytosis X, m ycosis fun goides , lymphomatoid pap ul os is, and 
denllatofibro m <1 sa rcoma pro tuberans (Willman el ai, 1994; Weiss 
el aI, 1985; Weiss cl ai, '1986 ; All an el ai, 1993 ) . 
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flects a polyclonal response by a group of cells to a 
growth stimulus is unknown. To provide further 
insight into the molecular events characterizing 
Bees. we deterIuined the clonal origin of five nodu-
lar Bees from a female patient by analyzing X 
chrolnosolue inactivation patterns at the HUMARA 
locus. All tUluors demonstrated a nonrandom pattern 
of X chrornosolne inactivation, consistent with 
monoclonal proliferation. These findings provide 
strong genetic evidence that sporadic Bees develop 
by clonal evolution and support the contention that a 
series of mutations in a single cell is responsible for 
the altered growth state seen in these transformed 
epithelial cells. Ke}, words: alldl'ogell l!eCeptor gelle 
(HUMARA)/restrictiol/ fragmel/t lel/gth POIJ' IIlOlpiJislll/pol),-
lIlemse clwill1'cactioll.j Invest Del'lllatoI106:579-582, 1996 
A conlm on m ethod used to determin e clonali ry of hulllan tumors 
is analysis of X chro mosom e inactiva tion patte rns in conjunctio n 
with pol ym o rphi c gen e loci (Vogclstein CI al. 1985; Vogelstein el ai, 
1987). Ea rly studies usin g t he X-lin ked po lymorphic ph osphoglyc-
erate kinase and h yp oxan thine phosph oribosyl- transfera se genes 
were limited in their usefuln ess beca use of a low fj'equ en cy of 
po lym o rphisms and variabl e m ethybrio n of the inactive X chro-
m osom e locll s (Willman ('I al. 1994 ; Allen el nl, 1992). Recently, a 
high.ly polym o rphic and co nsistently m ethyla ted polymorphic cy-
tosinc-ad eninc- g uanine trinucleotide repeat in the hum an androgen 
receptor gene (HUMARA: GenBank) has pro ven a reliab le m arke r 
to detel'mine X c hro m osom e in activation parterns in hum an tumors 
(Wi llman el al. 1994; Mashal ci al. 1993; All en ('I ai, 1992). 
T h e molecula r eve nts tha t characte rize th e develo pment of basa l 
ce ll ca rc in omas (.BCCs) a re no t understood. BCCs arc ind o lent, 
no nin vas ive. and rnrcl y m etastatic tumors that req uire underl ying 
stro l1l a for slI ccessful transplantation (Va n Scott ('I al . 1961: Flax-
man , 1968; Flax man , 1972). T hese data sugges t that BCCs are a 
m o re " differentiated" tUIll Or. A lterations in p53 an d loss of het-
e rozygos ity on c hro m oso m e 9 in BCCs suggest mutation-dri ven 
prolife ra tion (Gai l ani CI al. 1992: van del' R e it CI ai, 1994). It has n ot 
been clearly estabLished , h o wever, w hethe r BCCs res ult fi'om the 
acc LlnlLllatio n of Il'lut,uion s in a single ce ll with subseq uent clonal 
expansion or re Rect a gene ralized polyclonal response of a g ro up of 
cell s within a tissue to a ca rcinogeni c stimuli . 
To b egin to d e fine the clo nality of BCC, we determined X 
chro m osom e inactivation patterns in '~i ve BCCs fj 'om one fem ale 
patie n t using the po lym o rphic cytosine-adenine-guanine trinucle-
otid e r e peat sequence ill the HUM ARA gene in conjun ction with 
a methybtion sensiti ve en zym e and the po lym erase chain reaction 
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(PCR.). T h ese dat'l c lea rl y d e monstrate that BCCs, at lea st in t hi s 
individu al, d e monstrate a nonrandom pattern of X chro m oso m e 
inactivatio n and a re con sistent w ith the noti On t hat Bee re presents 
a 111 0noclo nal expansion of a ~ ing l e ce ll with altered growth 
contro l. 
MATERIALS AND METHODS 
Tissue Collection T he stud y W:lS :lpproved by the Scientific and I-I Ul11an 
Usc Committees, Depa rtmenr ofClinicallJlvestigation, Walter R eed A rm y 
Medical Ccntcr. Fo llowing informed consent. specil11 e.:ns of BCC were 
obta in ed fro lll the patient during Mohs microg"aphi c su rgery. All specim ens 
were obta ined oy deoulking curett:lge. For selected specin .cn, . a f,'ozen 
section of th e c urc.ttcd tum.o r W~I S p c rfOrn"l Cd to insure oprinlal SP CCil11CIl 
procurement (> 50
'
)';, tumor ce ll s). Norm:ll contro l tiss ue from the patient 
was generated fronl adjacent, nOIlJc.siOIl:l l skin d l1rll1g )"cCon strllctlon. Prior 
p:tra tl iu-c mbcddcd biopsy material se rved as t he hi stopatho logic di<l gI l0s is . 
Specim ens were fl as h frozcn ill liqu.id nitrogen ,,"d digested overnig ht in 
bulfer as described bel ow. 
DNA Extraction DNA was ex tracted from t Ulll o r o r l1 o n1131 tiss ue as 
previously described ill a d igestion buffet con ta inin g l(JO ,"M so diulll 
chlo ride, 16 mM Tris-H C L, 25 mM ethylene diamine tctra:l cetic acid 
(EDTA) , 0.5% sodium dodcc)'1 sulfate.:, D. l mg/ ,"I proteinase K, and Sll 
I.l.g/ml IlNAasc at J7"C for "1 - '18 h. dcp"nding On the size of the sample 
(A llan ('I nl, 1993). The diges ted sa l1lpks were th ell cxtmeted twice w ith a 
I: I mixture of phenol:chlorotOrl11. fo llowed by cwo ex tracrions w ith 
chl o ro forlll alo ne. T he sa ll1 ples were precipitated overni ght ill 0.1 vO'lUJ11C 
of 3 M sodiul11 ace tace and 2. 5 vol uJIl es of ethano l. T he DNA pe ller was 
dried. resuspended in water. and quan titated by OD2 r, .. · Puri ty of the sample 
was asce rtain ed by OD 2K\, and gel e lectrophoresis. 
Assessment ofClol1ality C loll"lity at the J-lUMAJ\A locus was assesscd 
by PC R alnpliti c;Jtioll ' IS previously described (AJ len el al. 1992). A tora l of 
1 (J ng to 1 l.Lg of DNA was digested overni ght at :n oc in a J D fJ-1 reac tion 
mix ture conta ining digestion hulle r alone o r 10 units of /-{f1 {/ JI with 
di ges tion buffer. The res tri c ti o n c Ilzynl cs \ve re then iJ1Cl Ctivf)tcd by he ati ng 
at '!soC for 10 min. For the PC I\ . 5 f.-I.I ofth c digested DNA w~s cO n.bill ed 
with 25 f.-I.I of PC R reac ti on mixture for:l final con cen tratiOn of 50 ml11 0l of 
potassi um chlo ride/I, '10 I11mo l ofTri s (1'1-1 8.3)/1. 1 .5 Illmol of magnes ium 
chloridc/I. 0.01 % ge la tin , 200 f.-I.l11ol of each deoxYl1l1c]eotide triphos-
phate / I, 5 pnlOl of each primer, 0.5 plllol of pri'" er 2 I ~ bc l e d with 
y I.P·I·' !-ATI' kinase , and 0 .05 ulli t ofTaq po lym erase. Thc sl!quences of the 
p rim ers used for amp l.ili cation in the I-IUM AI\A assay were 5'-GCTCT-
GAAGGTTGCTGTTCCT C AT-3 ' (pr imer J) and 5'T CCAGAATCTGT-
T CCAGAGCGTGC-3' (prilller 2) (A ll en el ,,/ , 1992). Ini tial denaturati on 
was performed for 7 min at 94°C. follow ed by 35 cycles of 45 s at 94 °C, 30 
s at OO °C. ,n.d 30 s at 72°C. After amplifi ca tion . 5 f.-I.I of sequenci '1g-
denaturing loading buffer was added to each tubc; the sa mpl es were he ated 
ar Y4 °C for 5 J11ill and thell l)ll Cn chcd vv ith icc . '"f h l! sarnplcs were \ o~ldcd on 
denaturing-sequcn cing gcls composed of B% 19: I ac rylal11ide: bisacrylamide 
ill 30% fOlTllamide, 4 M urea , and T"is borate EDTA bullet. T hc gels w<.! re 
run ,H 50 W for 5 h. dried , '"ld exposcd to x- ray tilm overnight 0" placed 
on a Phosporirn:lgcr screen for 2-1 h. 
For each sample. a corrected ratio (Table I) was calcuJated by di viding 
the ratio of the pre-digested 5(\llIplc (,lIl e1cl / allde 2) o btaincd aftcr 
digesting DNA with J-ll'a II, by the ratio of the Il on-pr,,-diges ted sample 
(a llele I/a JJ ele 2) obwined "fre r digesting DNA w ith digesti on ollJfer a lone 
'IS prev iously described (Willman cl oj , 19(4) . T he Use o f this ratio correct.ed 
to r the prcfercncinl ",nplification or o ll e ;dlcJc that rnight occur if eI, C alleles 
difFe red ITl:ukcdl y ill t he length o rthc ir repeats. o r ifrh e a ll c lc 0 11 rhe a c tive 
X chromosome was more easil y ampl ified. A l-; n,,1 clona l it)' ra t io for cach 
tUll10r w"s determined by di viding the correctcd ratio of the Iesion,,1 D NA 
b)' that o f the c!)ntml DNA , thereby normali z in g for unequal Iyo nizacion. 
T he perc\!ntagc of clonal cells was estimated b y comparing the fina l '-atio 
with " standard curve of allele "atios pl otte.:d "gainst pcrcenWges o f ci onal 
cell s (W illman cI nl , 199 '1). Experiments mix ing polyclonal and elOIl,,1 cell s 
have demonstrat.ed that the percellt:lge of clonal ,ell s can be l!stimated with 
an erro r of :':: '1 0%, and that a cional pOI.lLda tion of ce ll s ca ll be de tected if 
they constitu te more than 1 U- I 5'Y" of celh in >l polyelon;ll background 
(Willman ('/ "I, 11)94). 
R ESU LTS 
Patient T h e patie nt was a 76-y- o ld healthy white fema le w h o 
pres(; nted with a ton1l of five BCCs. T h e re was no prior hi story of 
Bce IIn ti l presenta tion . The p a ti e nt did n Ot exhibit any fe atures of 
the basa l cell n ev us syndl'ome and denied pre vious radiatio n 
therapy , inges ti on of Fow le r 's so lu tion, or histOry of excessive Sli n 
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exposu re. Samp les of aLI five BeCs w e re obtained for analysis . All 
tumors were presen t o n sun-exposed areas of the fa ce: foreh ead (8 
,-nm) , right ch eck (6 mm) , ri g ht n aso labia l fo ld (5 mill) , right upper 
lip (7 111111) , and left cheek (8 mm) . Histo logica ll y, all tumors 
demon strate d n od ular pattern s consistent with BCC. 
Analysis of Tumor DNA fi'om normal ti ssue of the patie nt was 
first analyzed to insure heterozygosity of the HUMARA locus. 
H ete rozygosity was indicated by two e quall y inte n se au toradio-
g raphic bands as pre viou sly described (Fig 1A) (A llen ef ai, 1992). 
A nonhete rozygo us ("u ninfo rm ative") pattern would havc been 
indicated by a marked diminucion in autoradiographic signal or 
compl ete loss o f one b and on the gel. T hen, patte rns of X 
chromosom e ina ctiv;ltion in tulllor tissue were cOl1lpared with 
th ose in nom1al t issu e Ii'om the pacient. All five tlll110 " specimens 
from thi s pati en t exhibi ted a sin gle c lone of cell s with n onrandom 
X inactivation as indic ated by a d iminution in the auto radiographic 
sig l1al (fi'actiona l a ll e le lo .,s) o r comple te loss of a band as comp'l red 
w ith normal control tiss ue (Fig lB, lif/) (Allen el ai, 1992). A 
calculate d pe rcenta ge of c lona l cell s in e ach tumor is shown in 
Table I (Willman d ai, 1994). Polyclo nal tumors would ha ve 
exhibited a random pattern of X chromosome ina ctivation indi-
cated by cwo equall y intense bands similar to nonlcsion a l tissue. 
DISC USSION 
It is generall y accepted that the d evelopment of any tumor, w hether 
benig n or malignant, deri ves Ii'olll a s ing le ce ll that is alcered b), a 
series of gen(;[i c mutations favori ng un controlled cell prolife ration 
(eav;mee and W hite, 1995; B ishop, 1991; Hunter , 1991). This 
proc e ss is known as elonal evolu tion (Cavanee an.d White , 1995) . 
Sequentia l mutation s of ge nomi c DNA with subseq ue nt clonal 
expansion can also charac te ri ze the transition from ,1 b enign to a 
malignant pro life ra tion. In neurofibromatosis , for example, che 
transformation of a n e urofibroma in to a ne urofibrosa rcoma is 
chara cterized by a transition ft'OIl1 a polyelonal to a monoclo[lal 
proliferation (]: ri edman el ai, 1 982). In thi s study of a sing le 
individual , we demonstrate that nodular B CCs d emonstrate a 
nonrandom patte rn of X chromo~ome ina ctivation. T hese data 
strongly suggest that BCC represents a monoclona l expansion of a 
sing le cell . 
Study of the clonal origin of human tumors ca n pro vide insight 
into both the mechani sllls th at unde rlie th e control(s) of cellular 
prolife ration ,md th e responses of vario us tis sues to known carcin-
oge n s such as ultraviolet lig h t (Vogelstcin cl ai, 1985; Voge lstein el 
ai, '1987). This is especially relevant for BCe. IfBCC resulted from 
muwtional events brou g ht about by long-term exposu re to ultra-
vio let light, exa mination of tumor DNA should d eillonstrate the 
expansion of a singl e c lo n e of ce ll s all co n taining the same genetic 
d e fec t(s). Alte rn atively, .if disordered g rowth resu lted 6'om ultra-
v iolet damage o f the unde rl ying mesenc h yme w ith libe ration of 
cytokines and growth factors, the tumor would demonstrate a 
polyclonal proliferation of cell s without a specific, single genetic 
defect. Our observations sho w th e fo rmer hypoth es is to be correct. 
H..ecent reports describing mutati o ns in the p53 tumor suppressor 
gen e (chromosom e 17) and a putative tumor supp ressor gene on 
chrom osome 9 support t.he co ncept of clonal evolution in BCCs 
and suggest potenti~1 loci that may be important in the molecular 
pathogenesi s of sporadic B CCs but do not directly prove clonal 
evo lu tion (Gailani CI ai , 1992; van del' Reit c( ai, 1994). In contrast, 
a recent cytogenetic study of two BCCs d escribe d c lonal and 
nonelonal cell populations (Kawa sak.i-Oyama (' I ai, 1994) bur 
cytogenetic studi es require ill I'i(ro culti v ation of tumor cells that can 
indu ce changes in DNA (Benn e tt, 1993 ). Add iti o nally, a stromal 
requ irem ent for BeC c ulti vation co uld contam inate tumor prepa-
rati ons and acco unt for the n on clonal alte ration s. T h e methods Ll sed 
in the present study to ana lyze purified tumor DNA have proved 
reliable ill previo us stud ies (Willman eI ({I, 1994; Mashalel ai, 1993) 
and c learly demonstrate c lo n al evolu tion ill ncc . 
The HUMA1~ assay to determin e clonality relics on three 
il11po rtant co ncepts re leva nt to moleculllr genetics : (i) random 
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F igure L COll1parison of X chronlosornc inactivation patterns in norn1.al skin and basal cell carcinoluas froll1 the patient using the 
HUMARA assay. A } It)i . DNA fi'OIll normal. nonJcsional skill ill lalles 1 alld 2 delllOLlstJ'a ting hete rozygosity (in tannative) at the f-IUMARA locus as 
depicted by two major bands. T he n"'jor bands represent amp li ficatio n units of approxillla tely 280 bp. " Shadow bands" directly below major bands res ul t 
from slippage of DNA polymerase during PCR amplification. Alleles a1ll1'Iitied in the absence (- ) or presence (+ ) or I-Ipo \I were qU <l ntit,l(ed with 
Phosphoritl1agc r anal ys is and arc shown at l-i g h t. Th e. left peak ill each scan represents th e :11110 1l1lt of rad ioactivity in the upper HUMA It.A :dlcl c . and the 
righ t peok represents the r<ldioactiv ity in the lower allcle. l30th alleles were amplified to a nearly equol degree in the contro l DNA. a pattern consistent with 
random X chromosome inactivation. B} le)i. shows amplified tumor DNA without (- ) and with (+ ) HJltI II trcannclI[ in IfillI'S 1 ond 2 (ta rehead). 3 and ~ 
(right check). 5 and 6 (right nasolabia l fo ld). 7 and 8 (right upper lip). and 9 and 10 (Iefe check) . Hf1(/ II-treat.ed specimens show complete loss orthe IIppel' 
alle le Or a dilllinutiOll of I allel e (fi-,lcti o lla l a ll e le loss) , p<lttc rn s consiste ll t with l1 o nra lld0l1 1 X chro mos() me inacti va tio n o r l11 onodonali ty. Andes frO ll1 rhe 
right check tulllor (lIIII" S 3,4) amplified in th e absence (- ) or presence (+ ) of HJln 1\ were qu anti tated with Phosphorlmager ana lys is and ore shown at ri ght. 
T he scan shows a st rikin g prcdOlllin:lncc of the lower I-IUMAllA allele. :l tinding consistent with n o nrillldo 111 X chro ill oso ine inactiva ti o n (c1olla li ty) . 
ina c tivation of 'l X chro moso me occLlrs in the somatic ce ll s of all 
ad ult female s with stable transmiss io n of thi s even t to all progeny of 
the origina l ce ll (Lyon hypothesis); (i i) c hanges in the activity of 
many genes Me accompanied by concomitant changes in th e 
methylation statLlS of cytosin e residu es ; and (iii) restri c tio n le ng th 
polymorphisms can be used to distinguish between X chro m oso mes 
derived fi'om the m othe r and th e hIthe r (Wi ll m an ('/ til, 1994; All e n 
e/ aI , 1992; Voge lstein ('/ ai, 1987) . Indeed, these concepts were 
used ill pre vious X chro m osom e inactivation studies of phospho -
glycerate kinase and hypoxanthine phosphoribosyl-transtc rase gene 
loci in detining the clona l natu re o f several Iymphoproliferative 
disorde rs (Gilliland ct al. 1991; va n Kamp rl aI, 1992; van Kamp CI 
aI , 1991) and ide n tifYing femal e carriers in human immunodefi -
ciency states (Greer e/ aI, 1989). 
A hig hly po lym orphi c cytosin c-ade nin e- g uanine trinucleotide 
repea t in the tlrst ex o n of the HUMARA gene has pro ved to be an 
excell en t candidate 10CllS for li se in X chromosome inac tivation 
analysis to dete rminc clo nality (Willman ('I ai, 1992; Alle n el aI, 
1992). Compared with previou sly reported X chromosom e po ly-
morphism s, the HUMARA trinucleotide repeat is hig h ly info rnl a-
tive (i.e., approximate ly 9 ()'X, of fema les are heterozygo us at this 
loc us, allowing assessment of tumor c1onality) and consistentl y 
methylated (Willman I'{ aI, 1994; Alle n c/ al . 1992). Methy latio n of 
Table I. Clonality of Basal Cell Carcinoma as 
Determined by the HUMARA Assay" 
Corrected R.atio 
Control DNA Les ion DNA 
0.98 
Fore hcad 12. 0 
Right cheek 6.()3 
Right nil sal fo ld 2 .07 
Right upper lip 3. 12 
Left check 1.94 















Hptl II sites less than 100 bp away from this polymorphic repeat 
co rre la tes with X inactivatio n (W illm an ('I al . 1994; All e n el aI, 
'1 992) . Foll ow ing Hp a 11 digestio n. PC R ampliti cation is abl e to 
di stin g ui sh between the mate rnal and pate rnal alleles. ide n tify the ir 
m e th yla tio n status. and depict X chro m oso m e in activat io n pa ttern s. 
T h e HUMARA assay requires DNA digestion w ith on ly a sin gle 
res tri c ti o n e n zyme and a sin gle PCR amplifi ca tion w ith o ne set of 
prime rs (Willman ('I al. 1994 ; Allen ('/ (/1, 1992). R.es ults arc 
considere d as re liabl e as Southe rn anal ysis (Al len 1'/ aI , 1992). 
All tlll110rs in this stud y displa yed nonrandom inactivatiOIl of the 
same X c hromosom e as indicated by the HUMA R A assay. T he 
signil'i c:l ll ce o f this findin g is uncl ea r. X chro m osom e in acti vation is 
compl ex and incompl etely unde rstood (A ll e n 1'/ aI, 1992). Rand o m 
X chrOll1 osom e inactiva tio n in normal tissue ON A with and 
without f-lpa II' digest io n as well as in tUlllor DNA wi tho ut Hpa 11 
digesti o n indicated a prope rly fu nction ing assay. h eterozygosity o f 
the HU MAR.A all e le in th is patient. nnd a la ck of skew in g 
(preferentia l ampl ifi cation of 'l all ele durin g PC R.). O ur findin gs 
raise the question whethe r BCCs m ay develop m o re comm on ly 
fi'om cell s with a spec ifi c patte1'1l of X chro m osom e in activatio n. 
In SUll1nlary, the HUMARA assay p rov ided a n elti cicnt and 
accurate m ethod of de terminin g clo n ali ty in BCC. Nonrandolll 
patte rns of X chromosom e inactivatio n in 5 BCCs suppo rt clonal 
evo lution and suggest that BCC is a member o f a g ro up of 
m onoclonal cutan eous tulllo rs th at displa y slow and noninvas ive 
g rowth . future efforts will foc us o n ex pandin g clo nal eva lu atio n in 
a la rger sel'ies of B CCs with va ri able histo logy, c lo nality in 
individual s w ith multiple 13CCs, nnd determining o ther genetic 
abnorm ali ties nssociated w ith th e a be rrant g rowth contro l seen in 
this epith e lial tumor. 
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